These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7453871)

  • 21. [On the problem of development of addiction by appetite depressants].
    Klinger W
    Z Arztl Fortbild (Jena); 1965 Jan; 59(1):49-50. PubMed ID: 5328577
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of a single dose of phenylpropanolamine following oral administration at two different times of the day.
    Rao VV; Rambhau D; Rao BR; Srinivasu P
    Arzneimittelforschung; 1998 Nov; 48(11):1087-90. PubMed ID: 9850430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathological anatomical lung chances caused by drug abuse (author's transl)].
    Debarge A; Lenoir L; Muller PH
    Acta Tuberc Pneumol Belg; 1979; 70(3-4):265-72. PubMed ID: 262938
    [No Abstract]   [Full Text] [Related]  

  • 24. Regarding "Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project": mercenary epidemiology--data reanalysis and reinterpretation for sponsors with financial interest in the outcome.
    Michaels D
    Ann Epidemiol; 2006 Jul; 16(7):583-5; author reply 586. PubMed ID: 16814150
    [No Abstract]   [Full Text] [Related]  

  • 25. Stroke and phenylpropanolamine use.
    Johnson DA; Etter HS; Reeves DM
    Lancet; 1983 Oct; 2(8356):970. PubMed ID: 6138529
    [No Abstract]   [Full Text] [Related]  

  • 26. Hazards of the appetite suppressant phenylpropanolamine.
    Bennett WM
    Lancet; 1979 Jul; 2(8132):42-3. PubMed ID: 87921
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDIES ON SOME CIRCULATORY EFFECTS OF PSEUDO-NOREPHEDRINE].
    ROSE W; TROGISCH J
    Z Gesamte Inn Med; 1963 Nov; 18():967-72. PubMed ID: 14112861
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of Akrinor-dependency (author's transl)].
    Laux G
    Nervenarzt; 1979 Feb; 50(2):121-3. PubMed ID: 424038
    [No Abstract]   [Full Text] [Related]  

  • 29. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
    Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
    J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug addiction from the etiological point of view (author's transl)].
    Curtet F
    Neuropsychiatr Enfance Adolesc; 1980; 28(7-8):291-3. PubMed ID: 7413025
    [No Abstract]   [Full Text] [Related]  

  • 31. [Newer drug addiction trends in juveniles].
    Ladewig D
    Schweiz Med Wochenschr; 1969 May; 99(21):781-3. PubMed ID: 5783065
    [No Abstract]   [Full Text] [Related]  

  • 32. Don't be so quick to ban medications.
    De FL
    CMAJ; 2002 Jan; 166(1):13. PubMed ID: 11800236
    [No Abstract]   [Full Text] [Related]  

  • 33. Case-control study was springboard for phenylpropanolamine action.
    Miller JL
    Am J Health Syst Pharm; 2000 Dec; 57(24):2254-5. PubMed ID: 11146967
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA issues public health advisory on phenylpropanolamine in drug products.
    Meadows M
    FDA Consum; 2001; 35(1):9. PubMed ID: 11930934
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical overuse: discussions of a typical case (author's transl)].
    Aubert C
    Schweiz Rundsch Med Prax; 1976 Feb; 65(5):127-9. PubMed ID: 1257206
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adolescents and drug-addiction (author's transl)].
    Braconnier A
    Arch Fr Pediatr; 1980; 37 Suppl 1():IX-X. PubMed ID: 7469717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dental considerations of patients taking appetite suppressants.
    Wynn RL
    Gen Dent; 1997; 45(4):324-8, 330-1. PubMed ID: 9515435
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dependence on benzodiazepines and appetite suppressants. An interview with Prof. B. Lemmer, Frankfurt].
    Lemmer B
    Med Monatsschr Pharm; 1981 Aug; 4(8):234-7. PubMed ID: 7266420
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet drugs: what a pill. Banned but unbowed.
    Brink S
    US News World Rep; 2000 Nov; 129(20):74. PubMed ID: 11186829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.